These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 18064817)
1. [Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously]. MMW Fortschr Med; 2007 Nov; 149(47):54. PubMed ID: 18064817 [No Abstract] [Full Text] [Related]
2. Tiotropium in chronic obstructive pulmonary disease. O'Connor AB N Engl J Med; 2009 Jan; 360(2):185-6; author reply 187. PubMed ID: 19137624 [No Abstract] [Full Text] [Related]
3. Tiotropium in chronic obstructive pulmonary disease. Chang ET N Engl J Med; 2009 Jan; 360(2):185; author reply 187. PubMed ID: 19137623 [No Abstract] [Full Text] [Related]
4. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator]. Izquierdo Alonso JL An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035 [TBL] [Abstract][Full Text] [Related]
5. [Often test the lungs of your patients! "Each patient should know his FEV1 value"]. MMW Fortschr Med; 2003 May; 145(19):57. PubMed ID: 12813989 [No Abstract] [Full Text] [Related]
6. Choice of bronchodilator therapy for patients with COPD. Wedzicha JA N Engl J Med; 2011 Mar; 364(12):1167-8. PubMed ID: 21428773 [No Abstract] [Full Text] [Related]
7. [Chronic obstructive pulmonary disease (COPD): diagnosis and treatment]. Kardos P Dtsch Med Wochenschr; 2004 Mar; 129(10):490-3. PubMed ID: 14986237 [No Abstract] [Full Text] [Related]
8. Tiotropium: a new, long-acting agent for the management of COPD--a clinical review. Crutchfield D Director; 2004; 12(3):160, 162-4. PubMed ID: 15323298 [TBL] [Abstract][Full Text] [Related]
9. [Long-acting m-cholinolytic thiotropium bromide (spiriva) in therapy of patients with chronic obstructive pulmonary disease (stage 3)]. Shmelev EI; Khmel'kova MA Ter Arkh; 2005; 77(12):74-6. PubMed ID: 16514826 [TBL] [Abstract][Full Text] [Related]
10. [Therapy of COPD. Reducing air trapping in the lung--improving physical capacity]. MMW Fortschr Med; 2005 May; 147(19):54-5. PubMed ID: 15940941 [No Abstract] [Full Text] [Related]
11. COPD and declining FEV1--time to divide and conquer? Reilly JJ N Engl J Med; 2008 Oct; 359(15):1616-8. PubMed ID: 18836214 [No Abstract] [Full Text] [Related]
16. [Tiotropium: a new therapeutic option in chronic obstructive pulmonary disease]. Corhay JL; Louis R Rev Med Suisse; 2005 Aug; 1(30):1967-9, 1971-2. PubMed ID: 16200941 [TBL] [Abstract][Full Text] [Related]
17. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators. Kitaguchi Y; Fujimoto K; Komatsu Y; Hanaoka M; Honda T; Kubo K Respir Med; 2013 Mar; 107(3):394-400. PubMed ID: 23245993 [TBL] [Abstract][Full Text] [Related]
18. [The first long-acting anticholinergic drug. COPD drug with 24-hour effect]. MMW Fortschr Med; 2002 Jun; 144(26):52. PubMed ID: 12154479 [No Abstract] [Full Text] [Related]